was funded by a LSRF fellowship
8.5 Geriatric Use In the SAXENDA clinical trials, 232 (6.9%) of the SAXENDA-treated patients were 65 years of age and over, and 17 (0.5%) of the SAXENDA-treated patients were 75 years of age and over
Almost half of all primary school teachers in England are encountering pupils with eating disorders at least occasionally, according to a survey of 10,000 teachers
During a discussion about KPV, Josh Mailman, president of the Neuroendocrine Tumor Research Foundation board of directors, said, Im voting on something here, but I dont know what that something is
FDA approval for semaglutide (Wegovy) for weight loss requires age 18 and older, while tirzepatide (Zepbound) carries the same requirement
At TrimRx, we believe that understanding the biological why behind your symptoms is the first step toward managing them effectively